Valuation: Attana AB

Market Cap 7.74M 812K 706K 657K 603K 1.14M 77.49M 1.16M 3.04M 38.58M 3.05M 2.98M 129M P/E 2024
-0.31x
P/E 2025 -1.11x
Enterprise Value 7.6M 796K 692K 644K 592K 1.12M 76.03M 1.13M 2.98M 37.85M 2.99M 2.93M 127M EV / Sales 2024
0.57x
EV / Sales 2025 5x
Free-Float
1.63%
Yield 2024 *
-
Yield 2025 -
3 months-57.14%
6 months-62.50%
Current year-66.67%
1 week 0
Extreme 0.003
0
1 month 0
Extreme 0.002
0
Current year 0
Extreme 0.002
0.01
1 year 0
Extreme 0.002
0.02
3 years 0
Extreme 0.002
0.32
5 years 0
Extreme 0.002
1.56
10 years 0
Extreme 0.002
2.4
Manager TitleAgeSince
Chief Executive Officer - 2025-03-31
Chief Executive Officer 56 2002-08-31
Director of Finance/CFO - -
Director TitleAgeSince
Director/Board Member 56 2012-08-05
Chairman 63 2015-09-30
Director/Board Member 62 2017-12-31
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-88.46%-98.88% 812K
-3.28%-1.67%-42.32%-47.92% 602M
+20.41%-27.10%+107.96% - 354M
-0.38%+2.32%+9.96%+67.72% 101M
+12.38%-3.65%-39.34%+0.88% 108M
Average +5.83%-5.37%-10.44%-19.55% 233.25M
Weighted average by Cap. +5.62%-8.42%+8.07%-27.08%

Financials

2024 2025
Net sales 6.61M 693K 603K 561K 515K 973K 66.19M 988K 2.6M 32.95M 2.6M 2.55M 111M 4.01M 420K 365K 340K 312K 590K 40.11M 599K 1.57M 19.97M 1.58M 1.54M 66.96M
Net income -12.78M -1.34M -1.16M -1.08M -995K -1.88M -128M -1.91M -5.01M -63.66M -5.03M -4.92M -213M -10.5M -1.1M -957K -891K -818K -1.54M -105M -1.57M -4.12M -52.33M -4.14M -4.04M -175M
Net Debt 1.17M 123K 107K 99.34K 91.21K 172K 11.72M 175K 460K 5.83M 461K 451K 19.56M -145K -15.25K -13.26K -12.34K -11.33K -21.39K -1.46M -21.72K -57.08K -725K -57.27K -56.01K -2.43M
Logo Attana AB
Attana AB is a Sweden-based biotechnology company specializing in in vitro characterization of molecular interactions mimicking in vivo conditions. The Company develops proprietary label-free biosensors, based on the Quartz Crystal Microbalance (QCM) technology, for biochemical, crude, sera and cell-based assays. Its products and research services are used by pharmaceutical and biotechnology companies to quality control the production line of a biological pharmaceutical or gain insight into advanced dynamic features of target molecules, as well as by academic institutions within the life sciences. Attana’s biosensors are used to determine specificity, kinetics and affinity, among other binding characteristics of biomolecules and macrostructures of varying species such as cells, antibodies, proteins, viruses and bacteria.
Employees
6
Date Price Change Volume
26-07-31 SEK 0.003000 -.--% 3,779,394
26-07-30 SEK 0.003000 -.--% 1,199,048
26-07-29 SEK 0.003000 -.--% 33,895,041
26-07-28 SEK 0.003000 -.--% 3,225,168
26-07-27 SEK 0.003000 -.--% 4,800,508
  1. Stock Market
  2. Stocks
  3. ATANA Stock